China Biologic Products, Inc. (CBPO)
(Delayed Data from NSDQ)
$94.62 USD
-5.59 (-5.58%)
Updated May 3, 2019 04:00 PM ET
After-Market: $94.44 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$94.62 USD
-5.59 (-5.58%)
Updated May 3, 2019 04:00 PM ET
After-Market: $94.44 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
China Biologic Products (CBPO) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
China Biologic Products (CBPO) delivered earnings and revenue surprises of 12.12% and 8.61%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: China Biologic Products (CBPO) Q1 Earnings Expected to Decline
by Zacks Equity Research
China Biologic Products (CBPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate China Biologic Products (CBPO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
China Biologic Products (CBPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 9th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
New Strong Sell Stocks for April 4th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for March 22nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for March 20th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for March 18th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
China Biologic Products (CBPO) Looks Good: Stock Adds 8.7% in Session
by Zacks Equity Research
China Biologic Products (CBPO) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
New Strong Sell Stocks for January 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday
New Strong Sell Stocks for January 18th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday